Raymond James analyst James Rollyson raised the firm’s price target on NOV Inc. (NOV) to $19 from $18 and keeps an Outperform rating on the shares. NOV reported an across the board beat, ending the year in a solid position with a strong free cash flow performance, the analyst tells investors in a research note. Similar to others, the 2025 top line outlook is flattish, and Raymond James says NOV remains in the “prove it” stage of its new capital return program.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio